BioNTech Future Growth

Future criteria checks 0/6

BioNTech is forecast to grow earnings and revenue by 12.4% and 3.5% per annum respectively. EPS is expected to grow by 10.6% per annum. Return on equity is forecast to be -2% in 3 years.

Key information

12.4%

Earnings growth rate

10.6%

EPS growth rate

Biotechs earnings growth36.4%
Revenue growth rate3.5%
Future return on equity-2.0%
Analyst coverage

Good

Last updated02 Dec 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

LSE:0A3M - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,599-787-1,021-1,02414
12/31/20252,580-813179-60118
12/31/20242,611-76546876116
9/30/20243,040-4679711,522N/A
6/30/20242,691-5042,3522,972N/A
3/31/20242,7301134,9445,732N/A
12/31/20233,8199304,6665,371N/A
9/30/20236,6182,7514,6905,350N/A
6/30/20239,1844,3758,7269,317N/A
3/31/202312,2136,2388,4938,850N/A
12/31/202217,3119,43413,21413,577N/A
9/30/202218,56510,32212,27712,549N/A
6/30/202221,19111,7489,0409,271N/A
3/31/202223,30312,8635,0665,251N/A
12/31/202118,97710,293736890N/A
9/30/202113,7907,4931,1981,338N/A
6/30/20217,7704,072-474-355N/A
3/31/20212,5031,197-376-270N/A
12/31/202048215-99-13N/A
9/30/2020165-410-382-326N/A
6/30/2020126-230-239-183N/A
3/31/2020110-192-268-222N/A
12/31/2019109-179-270-198N/A
9/30/2019144-122-220-138N/A
6/30/2019136-116-142-75N/A
3/31/2019132-77-136-55N/A
12/31/2018128-48-126-59N/A
12/31/201762-86N/A-53N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 0A3M is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: 0A3M is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: 0A3M is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: 0A3M's revenue (3.5% per year) is forecast to grow slower than the UK market (3.6% per year).

High Growth Revenue: 0A3M's revenue (3.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 0A3M is forecast to be unprofitable in 3 years.


Discover growth companies